![](/assets/artwork/1x1-42817eea7ade52607a760cbee00d1495.gif)
OmimO 17+
Pharmacist Revision Buddy
OMIMO Pharma Inc.
Designed for iPad
-
- Free
- Offers In-App Purchases
Screenshots
Description
Have you ever experienced a moment where you were reviewing recently learned clinical information, only to feel like you had never encountered it before in your life?
You're not alone! Almost everyone faces this uphill battle against an invisible enemy known as the forgetting curve.
The forgetting curve, first identified by German psychologist Hermann Ebbinghaus, reveals that if we learn something new but make no attempt to relearn that information, we remember less and less of it as the days and weeks go by, until it fades completely from memory.
This can present a significant challenge for pharmacists aiming to keep their knowledge up-to-date and for students preparing to write the PEBC exams.
Meet OmimO – your game-changing revision buddy!
OmimO delivers new questions daily. Take a moment to recall each answer before checking the correct one. Then, rate your memory:
Green for complete mastery,
Yellow for partial recall, and
Red for total forgetfulness.
Powered by a sophisticated algorithm inspired by Ebbinghaus's research, OmimO schedules your initial reviews at key moments to effectively tackle memory loss. As you progress, it uses your ratings to plan your next review, prioritizing sooner revisits for challenging content.
Subscription Details:
Subscription Fee: $14.99 CAD per month.
Auto-Renewal: The subscription automatically renews each month unless cancelled by the user.
Access and Features:
Subscribers have continuous access to all OmimO content for the duration of their subscription. However, it’s important to note that the content is not downloadable and cannot be accessed once the subscription ends.
Diverse Content Library: OmimO’s library encompasses 141 topics, including a wide array of clinical topics such as Diabetes, Cardiovascular Diseases, Depression, ADHD, etc., alongside practical skills like counseling, billing and adjudication, and other foundational skills. This rich variety ensures that OmimO caters to the broad spectrum of needs for Canadian pharmacists and candidates preparing for the PEBC exams.
Adaptability to Study Needs: Users can tailor their study experience by choosing their preferred study level—PEBC Evaluating Exam, PEBC MCQ Exam, PEBC OSCE Exam, or Licensed Pharmacist. The flexibility to switch between levels as needed allows for a customized revision path that aligns with the user's progression and goals.
Flexible Study Sessions: Subscribers can customize their daily study sessions by choosing the number of new information cards and review cards.
Interactive Learning: Users rate each piece of information based on difficulty (easy, medium, or hard), using color-coded buttons (green, yellow, or red).
Personalized Revision Schedule: The app’s algorithm calculates the optimal time to revisit information based on user ratings, enhancing memory retention.
This comprehensive package not only offers an invaluable resource for ongoing education but also aligns with the convenience and affordability of today’s digital subscription services, making it an essential tool for professionals seeking to maintain and enhance their knowledge in the field.
Purpose and Scope: OmimO is designed as a comprehensive revision tool to supplement, not replace, other study sources. While it provides extensive coverage of relevant topics, it is not intended to be the sole resource for exam preparation or professional development.
Independence from PEBC: OmimO is not affiliated with the Pharmacy Examining Board of Canada (PEBC). “PEBC” and “Pharmacy Examining Board of Canada” are trademarks of the Pharmacy Examining Board of Canada, and OmimO operates independently as a revision and educational tool.
-----
Our Privacy Policy: https://www.omimo.ca/privacy
Terms of service: https://www.apple.com/legal/internet-services/itunes/dev/stdeula/
Learn More about how we create our content: https://www.omimo.ca/content
Get to know how to use OmimO: https://www.omimo.ca/demo
What’s New
Version 1.1.0
- Minor bug fixes and performance improvements
App Privacy
The developer, OMIMO Pharma Inc., indicated that the app’s privacy practices may include handling of data as described below. For more information, see the developer’s privacy policy.
Data Linked to You
The following data may be collected and linked to your identity:
- Contact Info
Data Not Linked to You
The following data may be collected but it is not linked to your identity:
- Contact Info
Privacy practices may vary based on, for example, the features you use or your age. Learn More
Information
- Provider
- OMIMO Pharma Inc
- Size
- 32.7 MB
- Category
- Education
- Compatibility
-
- iPhone
- Requires iOS 17.0 or later.
- iPad
- Requires iPadOS 17.0 or later.
- Mac
- Requires macOS 14.0 or later and a Mac with Apple M1 chip or later.
- Apple Vision
- Requires visionOS 1.0 or later.
- Languages
-
English
- Age Rating
- 17+ Infrequent/Mild Alcohol, Tobacco, or Drug Use or References Frequent/Intense Medical/Treatment Information
- Copyright
- © 2024 OMIMO Pharma inc
- Price
- Free
- In-App Purchases
-
- OmimO Monthly USD 11.99